Innospec Inc. logo

Innospec Inc. (IOSP)

Market Open
11 Sep, 14:10
NASDAQ (NGS) NASDAQ (NGS)
$
92. 91
-0.17
-0.1826%
$
2.31B Market Cap
23.64 P/E Ratio
1.84% Div Yield
6,750 Volume
5.87 Eps
$ 93.08
Previous Close
Add Transaction
Day Range
92.48 93.83
Year Range
65.51 96.68
Want to track IOSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innospec Inc. (IOSP) Q1 2026 Earnings Call Transcript

Innospec Inc. (IOSP) Q1 2026 Earnings Call Transcript

Innospec Inc. (IOSP) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 months ago
Innospec (IOSP) Surpasses Q1 Earnings and Revenue Estimates

Innospec (IOSP) Surpasses Q1 Earnings and Revenue Estimates

Innospec (IOSP) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.42 per share a year ago.

Zacks | 4 months ago
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago
Is the Options Market Predicting a Spike in Innospec Stock?

Is the Options Market Predicting a Spike in Innospec Stock?

Investors need to pay close attention to IOSP stock based on the movements in the options market lately.

Zacks | 4 months ago
Will Innospec (IOSP) Beat Estimates Again in Its Next Earnings Report?

Will Innospec (IOSP) Beat Estimates Again in Its Next Earnings Report?

Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 4 months ago
Innospec (IOSP) Down 21.8% Since Last Earnings Report: Can It Rebound?

Innospec (IOSP) Down 21.8% Since Last Earnings Report: Can It Rebound?

Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?

Zacks | 5 months ago
Innospec: Oilfield Services Bound For A Recovery

Innospec: Oilfield Services Bound For A Recovery

Innospec is positioned as a likely beneficiary of energy shortages and rising oil prices, supplying vital chemicals for oil extraction and refining. IOSP trades at a 50% discount to sector P/E and EV/EBITDA multiples, despite a debt-free balance sheet and strong free cash flow generation. Operational catalysts include potential recovery in oilfield services, resolution of the Mexico crisis, and increased demand from geopolitical disruptions.

Seekingalpha | 6 months ago
What's Driving Innospec Stock in FY26 After the Winter Storm

What's Driving Innospec Stock in FY26 After the Winter Storm

IOSP faces a storm-hit start to 2026 as lost Performance Chemicals volumes delay recovery, leaving Fuel Specialties to steady results until a second-half rebound.

Zacks | 6 months ago
Storm Fallout and Segment Reset: What's Next for Innospec Stock?

Storm Fallout and Segment Reset: What's Next for Innospec Stock?

IOSP faces a storm-hit start to 2026 with weaker H1 earnings with recovery now hinges on a second-half rebound in Performance Chemicals and Oilfield Services.

Zacks | 6 months ago
Innospec Inc. (IOSP) Q4 2025 Earnings Call Transcript

Innospec Inc. (IOSP) Q4 2025 Earnings Call Transcript

Innospec Inc. (IOSP) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago
Innospec (IOSP) Tops Q4 Earnings Estimates

Innospec (IOSP) Tops Q4 Earnings Estimates

Innospec (IOSP) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.41 per share a year ago.

Zacks | 6 months ago
Innospec: Personal Care Margins Crack, But The Cycle Will Turn Again

Innospec: Personal Care Margins Crack, But The Cycle Will Turn Again

Innospec has faced significant margin pressure in Performance Chemicals and overall weakness in Oilfield Services, driving a 20% share price decline. Secular challenges like consumer down-trading and higher oleochemical costs have sharply contracted margins, but these headwinds should be largely cyclical. Management is implementing self-help initiatives and expects product launches in late 2025 to support a return to growth by 2026.

Seekingalpha | 8 months ago
Loading...
Load More